BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34806611)

  • 1. Mitochondrial Membrane Potential Influences Amyloid-β Protein Precursor Localization and Amyloid-β Secretion.
    Wilkins HM; Troutwine BR; Menta BW; Manley SJ; Strope TA; Lysaker CR; Swerdlow RH
    J Alzheimers Dis; 2022; 85(1):381-394. PubMed ID: 34806611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the Amyloid-β Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-β Peptide.
    Pope CA; Wilkins HM; Swerdlow RH; Wolfe MS
    J Alzheimers Dis; 2021; 83(3):1039-1049. PubMed ID: 34366346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-β Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAβPPα.
    Owens L; Bracewell J; Benedetto A; Dawson N; Gaffney C; Parkin E
    J Alzheimers Dis; 2022; 86(3):1201-1220. PubMed ID: 35180123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Characterization of Intact Cells Reveals Intracellular Amyloid Beta but Not Its Precursor Protein to Reduce Mitochondrial Respiration.
    Schaefer PM; von Einem B; Walther P; Calzia E; von Arnim CA
    PLoS One; 2016; 11(12):e0168157. PubMed ID: 28005987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
    Hook G; Yu J; Toneff T; Kindy M; Hook V
    J Alzheimers Dis; 2014; 41(1):129-49. PubMed ID: 24595198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
    Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
    Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation.
    Marwarha G; Rostad S; Lilek J; Kleinjan M; Schommer J; Ghribi O
    J Alzheimers Dis; 2017; 57(3):907-925. PubMed ID: 28304295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase.
    Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H
    J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria are devoid of amyloid β-protein (Aβ)-producing secretases: Evidence for unlikely occurrence within mitochondria of Aβ generation from amyloid precursor protein.
    Mamada N; Tanokashira D; Ishii K; Tamaoka A; Araki W
    Biochem Biophys Res Commun; 2017 Apr; 486(2):321-328. PubMed ID: 28302486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation and Glycosylation of Amyloid-β Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer's Disease.
    Song XJ; Zhou HY; Sun YY; Huang HC
    J Alzheimers Dis; 2021; 84(3):937-957. PubMed ID: 34602469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPP-β Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.
    Resende R; Ferreira-Marques M; Moreira P; Coimbra JRM; Baptista SJ; Isidoro C; Salvador JAR; Dinis TCP; Pereira CF; Santos AE
    J Alzheimers Dis; 2020; 76(4):1317-1337. PubMed ID: 32597812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of curcumin on H
    Song XJ; Zhou HY; Sun YX; Huang HC
    Mol Biol Rep; 2020 Mar; 47(3):2047-2059. PubMed ID: 32036572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.
    Vaillant-Beuchot L; Mary A; Pardossi-Piquard R; Bourgeois A; Lauritzen I; Eysert F; Kinoshita PF; Cazareth J; Badot C; Fragaki K; Bussiere R; Martin C; Mary R; Bauer C; Pagnotta S; Paquis-Flucklinger V; Buée-Scherrer V; Buée L; Lacas-Gervais S; Checler F; Chami M
    Acta Neuropathol; 2021 Jan; 141(1):39-65. PubMed ID: 33079262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.
    Miyamoto M; Kuzuya A; Noda Y; Ueda S; Asada-Utsugi M; Ito S; Fukusumi Y; Kawachi H; Takahashi R; Kinoshita A
    J Alzheimers Dis; 2020; 75(1):173-185. PubMed ID: 32280101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease.
    Agostinho P; Pliássova A; Oliveira CR; Cunha RA
    J Alzheimers Dis; 2015; 45(2):329-47. PubMed ID: 25589722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer's Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime-Only Depletion of Intraneuronal Aβ (
    Volloch V; Rits-Volloch S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cell model for the initial phase of sporadic Alzheimer's disease.
    Stockburger C; Gold VA; Pallas T; Kolesova N; Miano D; Leuner K; Müller WE
    J Alzheimers Dis; 2014; 42(2):395-411. PubMed ID: 24898661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.
    Metsla K; Kirss S; Laks K; Sildnik G; Palgi M; Palumaa T; Tõugu V; Palumaa P
    J Alzheimers Dis; 2022; 85(2):715-728. PubMed ID: 34864665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of Amyloid-β Levels by Curcumin Derivative via Modulation of Amyloid-β Protein Precursor Trafficking.
    Kotani R; Urano Y; Sugimoto H; Noguchi N
    J Alzheimers Dis; 2017; 56(2):529-542. PubMed ID: 27983550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.